These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24289797)

  • 21. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
    Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder.
    Abdel-Baki A; Thibault D; Medrano S; Stip E; Ladouceur M; Tahir R; Potvin S
    Early Interv Psychiatry; 2020 Feb; 14(1):69-79. PubMed ID: 31125513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of symptom resolution on medication adherence in first episode psychosis.
    Steger KA; Cassidy C; Rabinovitch M; Joober R; Malla A
    Psychiatry Res; 2012 Mar; 196(1):45-51. PubMed ID: 22377571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.
    Ricci V; Ceci F; Di Carlo F; Lalli A; Ciavoni L; Mosca A; Sepede G; Salone A; Quattrone D; Fraticelli S; Maina G; Martinotti G
    Drug Alcohol Depend; 2021 Dec; 229(Pt A):109118. PubMed ID: 34688166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
    Hides L; Dawe S; Kavanagh DJ; Young RM
    Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort.
    Setién-Suero E; Neergaard K; Ortiz-García de la Foz V; Suárez-Pinilla P; Martínez-García O; Crespo-Facorro B; Ayesa-Arriola R
    Acta Psychiatr Scand; 2019 Oct; 140(4):349-359. PubMed ID: 31381129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program.
    Abdel-Baki A; Ouellet-Plamondon C; Salvat É; Grar K; Potvin S
    Psychiatry Res; 2017 Jan; 247():113-119. PubMed ID: 27888680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cannabis on weight and metabolism in first-episode non-affective psychosis: Results from a three-year longitudinal study.
    Vázquez-Bourgon J; Setién-Suero E; Pilar-Cuéllar F; Romero-Jiménez R; Ortiz-García de la Foz V; Castro E; Crespo-Facorro B
    J Psychopharmacol; 2019 Mar; 33(3):284-294. PubMed ID: 30702972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients.
    Vázquez-Bourgon J; Ortiz-García de la Foz V; Suarez-Pereira I; Iruzubieta P; Arias-Loste MT; Setién-Suero E; Ayesa-Arriola R; Gómez-Revuelta M; Crespo J; Crespo Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109677. PubMed ID: 31228640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    de Vos C; Leopold K; Blanke ES; Siebert S; Baumgardt J; Burkhardt E; Bechdolf A
    Psychiatry Res; 2020 Nov; 293():113424. PubMed ID: 32862065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for antipsychotic medication non-adherence behaviors and attitudes in adult-onset psychosis.
    Hui CLM; Poon VWY; Ko WT; Miao HY; Chang WC; Lee EHM; Chan SKW; Lin J; Chen EYH
    Schizophr Res; 2016 Jul; 174(1-3):144-149. PubMed ID: 27050476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis.
    Pelayo-Terán JM; Diaz FJ; Pérez-Iglesias R; Suárez-Pinilla P; Tabarés-Seisdedos R; de León J; Crespo-Facorro B
    Psychol Med; 2014 Jan; 44(1):37-50. PubMed ID: 23461899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning.
    Sánchez-Gutiérrez T; Fernandez-Castilla B; Barbeito S; González-Pinto A; Becerra-García JA; Calvo A
    Eur Psychiatry; 2020 Jan; 63(1):e6. PubMed ID: 32093788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological assessment of memory in child and adolescent first episode psychosis: cannabis and «the paradox effect».
    Moreno-Granados JM; Ferrín M; Salcedo-Marín DM; Ruiz-Veguilla M
    Rev Psiquiatr Salud Ment; 2014; 7(1):13-24. PubMed ID: 23830215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication adherence in first-episode psychosis patients in Singapore.
    Tan C; Abdin E; Liang W; Poon LY; Poon NY; Verma S
    Early Interv Psychiatry; 2019 Aug; 13(4):780-788. PubMed ID: 29521010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.
    Daneault JG; Maraj A; Lepage M; Malla A; Schmitz N; Iyer SN; Joober R; Shah JL
    Acta Psychiatr Scand; 2019 Apr; 139(4):336-347. PubMed ID: 30712261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up.
    Opsal A; Clausen T; Kristensen O; Elvik I; Joa I; Larsen TK
    Acta Psychiatr Scand; 2011 Sep; 124(3):198-204. PubMed ID: 21418161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.